JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
158 hedge funds and large institutions have $2.34B invested in Juno Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 52 increasing their positions, 45 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 160 → 158 (-2)
11% less capital invested
Capital invested by funds: $2.61B → $2.34B (-$275M)
Holders
158
Holding in Top 10
4
Calls
$46.6M
Puts
$24.6M
Top Buyers
| 1 | +$405M | |
| 2 | +$37.8M | |
| 3 | +$37.6M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$19.1M |
| 5 |
Millennium Management
New York
|
+$9.66M |
Top Sellers
| 1 | -$324M | |
| 2 | -$60.4M | |
| 3 | -$44.6M | |
| 4 |
BAMCO Inc
New York
|
-$8.79M |
| 5 |
Goldman Sachs
New York
|
-$8.7M |